Tenet Healthcare Co. (NYSE:THC - Get Free Report) Director James L. Bierman sold 13,836 shares of Tenet Healthcare stock in a transaction on Friday, May 23rd. The stock was sold at an average price of $159.58, for a total value of $2,207,948.88. Following the sale, the director now owns 41,435 shares of the company's stock, valued at approximately $6,612,197.30. This trade represents a 25.03% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website.
Tenet Healthcare Stock Up 1.5%
NYSE THC traded up $2.56 during trading on Friday, hitting $168.82. The company's stock had a trading volume of 2,250,200 shares, compared to its average volume of 1,516,611. The company has a debt-to-equity ratio of 2.25, a current ratio of 1.78 and a quick ratio of 1.70. The company has a market cap of $15.68 billion, a PE ratio of 5.24, a P/E/G ratio of 1.02 and a beta of 1.63. The business's 50 day simple moving average is $140.71 and its 200-day simple moving average is $136.62. Tenet Healthcare Co. has a fifty-two week low of $109.82 and a fifty-two week high of $171.20.
Tenet Healthcare (NYSE:THC - Get Free Report) last issued its quarterly earnings results on Tuesday, April 29th. The company reported $4.36 earnings per share for the quarter, topping the consensus estimate of $3.11 by $1.25. Tenet Healthcare had a return on equity of 21.88% and a net margin of 15.48%. The business had revenue of $5.22 billion during the quarter, compared to the consensus estimate of $5.15 billion. During the same quarter last year, the company earned $3.22 earnings per share. The company's quarterly revenue was down 2.5% on a year-over-year basis. On average, equities analysts anticipate that Tenet Healthcare Co. will post 12.24 EPS for the current fiscal year.
Institutional Investors Weigh In On Tenet Healthcare
A number of institutional investors and hedge funds have recently modified their holdings of THC. Loring Wolcott & Coolidge Fiduciary Advisors LLP MA acquired a new stake in shares of Tenet Healthcare during the first quarter worth about $26,000. Wayfinding Financial LLC acquired a new stake in shares of Tenet Healthcare during the first quarter worth about $28,000. SVB Wealth LLC acquired a new stake in shares of Tenet Healthcare during the first quarter worth about $30,000. Colonial Trust Co SC lifted its holdings in shares of Tenet Healthcare by 85.7% during the fourth quarter. Colonial Trust Co SC now owns 247 shares of the company's stock worth $31,000 after purchasing an additional 114 shares during the period. Finally, N.E.W. Advisory Services LLC acquired a new position in Tenet Healthcare in the first quarter valued at approximately $31,000. Institutional investors and hedge funds own 95.44% of the company's stock.
Analysts Set New Price Targets
Several brokerages have recently commented on THC. Robert W. Baird restated a "neutral" rating and set a $137.00 price target (down previously from $153.00) on shares of Tenet Healthcare in a research note on Tuesday, April 15th. Barclays raised their price target on Tenet Healthcare from $161.00 to $171.00 and gave the company an "overweight" rating in a research note on Wednesday, April 30th. Truist Financial raised their price target on Tenet Healthcare from $175.00 to $190.00 and gave the company a "buy" rating in a research note on Monday, May 12th. The Goldman Sachs Group raised their price target on Tenet Healthcare from $134.00 to $154.00 and gave the company a "neutral" rating in a research note on Monday, May 5th. Finally, TD Cowen initiated coverage on Tenet Healthcare in a research note on Wednesday, February 26th. They set a "buy" rating and a $175.00 price target on the stock. Three research analysts have rated the stock with a hold rating and sixteen have given a buy rating to the stock. According to MarketBeat.com, the company has a consensus rating of "Moderate Buy" and a consensus price target of $177.59.
View Our Latest Stock Report on Tenet Healthcare
About Tenet Healthcare
(
Get Free Report)
Tenet Healthcare Corporation operates as a diversified healthcare services company in the United States. The company operates through two segments: Hospital Operations and Services, and Ambulatory Care. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies.
See Also

Before you consider Tenet Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Tenet Healthcare wasn't on the list.
While Tenet Healthcare currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.